Companies
Pacific Biosciences of California Inc [PACB] is -30.60% lower this YTD. Is it still time to buy?
Pacific Biosciences of California Inc [NASDAQ: PACB] price plunged by -3.79 percent to reach at -$0.05. The one-year PACB stock forecast points to a potential upside of 39.52. The average equity rating for PACB stock is currently 2.27, trading closer to a bullish pattern in